Written question asked by Alan Johnson (Labour) on Tuesday, 17 January 2017, in the House of Commons. It was due for an answer on Thursday, 19 January 2017. It was answered by David Mowat (Conservative) on Wednesday, 25 January 2017 on behalf of the Department of Health.
NHS: Procurement
- Question
-
To ask the Secretary of State for Health, what steps the NHS Business Services Authority has taken to provide right of appeal by patients and industry as part of the NHS Clinical Evaluation Team's process to review NHS products.
- Answer
-
The Clinical Evaluation Team is not seeking to establish a set of standards for products, nor does it purport to make any recommendations for the National Health Service to use (or not use) particular products. Suppliers are to be given the opportunity to review the Clinical Evaluation Team’s reviews for their product(s) at least 72 hours in advance of publication so that any factual and material errors can be rectified. Any concerns expressed will be given appropriate consideration.
Secondary information
- Type
- Written question
- Reference
- 60258
- Session
- 2016-17
- Subjects
- Appeals NHS Medical treatments Procurement
- Link
- View this Written question on www.parliament.uk
Librarians' tools
- Timestamp
- 2017-01-25 18:14:58 +0000
- URI
- http://data.parliament.uk/writtenparliamentaryquestion/commons/2016-17/60258
- In Indexing
- http://indexing.parliament.uk/Content/Edit/1?uri=http://data.parliament.uk/writtenparliamentaryquestion/commons/2016-17/60258
- In Solr
- https://search.parliament.uk/claw/solr/?id=http://data.parliament.uk/writtenparliamentaryquestion/commons/2016-17/60258